• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Exec. Chairman & Co-Founder Mecklenburg Gabriel M.I. converted options into 83,334 shares and sold $5,018,133 worth of shares (83,334 units at $60.22) as part of a pre-agreed trading plan (SEC Form 4)

    6/3/26 4:23:42 PM ET
    $HNGE
    EDP Services
    Technology
    Get the next $HNGE alert in real time by email
    SEC FORM 4SEC Form 4
    FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number:3235-0287
    Estimated average burden
    hours per response:0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    X
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Mecklenburg Gabriel M.I.

    (Last)(First)(Middle)
    C/O HINGE HEALTH, INC.
    455 MARKET STREET, SUITE 700

    (Street)
    SAN FRANCISCO CALIFORNIA 94105

    (City)(State)(Zip)

    UNITED STATES

    (Country)
    2. Issuer Name and Ticker or Trading Symbol
    Hinge Health, Inc. [ HNGE ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    XDirector10% Owner
    Officer (give title below)XOther (specify below)
    Exec. Chairman & Co-Founder
    2a. Foreign Trading Symbol
    3. Date of Earliest Transaction (Month/Day/Year)
    06/01/2026
    6. Individual or Joint/Group Filing (Check Applicable Line)
    XForm filed by One Reporting Person
    Form filed by More than One Reporting Person
    4. If Amendment, Date of Original Filed (Month/Day/Year)

    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    CodeVAmount(A) or (D)Price
    Class A Common Stock06/01/2026C83,334A$083,334D
    Class A Common Stock06/01/2026S(1)1,200D$55.7421(2)82,134D
    Class A Common Stock06/01/2026S(1)2,542D$56.9692(3)79,592D
    Class A Common Stock06/01/2026S(1)4,258D$57.6717(4)75,334D
    Class A Common Stock06/01/2026S(1)14,285D$58.9423(5)61,049D
    Class A Common Stock06/01/2026S(1)6,853D$60.1936(6)54,196D
    Class A Common Stock06/01/2026S(1)48,596D$60.93(7)5,600D
    Class A Common Stock06/01/2026S(1)5,600D$61.6801(8)0D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
    Class B Common Stock(9)06/01/2026C83,334 (9) (9)Class A Common Stock83,334$01,777,341(10)D
    Class B Common Stock(9) (9) (9)Class A Common Stock857,880857,880IBy GRAT
    Class B Common Stock(9) (9) (9)Class A Common Stock383,592383,592IBy Family Trust
    Explanation of Responses:
    1. The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025.
    2. Represents the weighted average sale price. The lowest price at which shares were sold was $55.21 and the highest price at which shares were sold was $55.82. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
    3. Represents the weighted average sale price. The lowest price at which shares were sold was $56.38 and the highest price at which shares were sold was $57.37. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
    4. Represents the weighted average sale price. The lowest price at which shares were sold was $57.38 and the highest price at which shares were sold was $58.29. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
    5. Represents the weighted average sale price. The lowest price at which shares were sold was $58.41 and the highest price at which shares were sold was $59.32. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
    6. Represents the weighted average sale price. The lowest price at which shares were sold was $59.52 and the highest price at which shares were sold was $60.51. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
    7. Represents the weighted average sale price. The lowest price at which shares were sold was $60.52 and the highest price at which shares were sold was $61.51. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
    8. Represents the weighted average sale price. The lowest price at which shares were sold was $61.52 and the highest price at which shares were sold was $62.07. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
    9. Each share of Class B Common Stock is convertible into one share of the lssuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.
    10. Excludes 944,250 performance stock units held by the Reporting Person.
    /s/ James Budge, Attorney-in-Fact06/03/2026
    ** Signature of Reporting PersonDate
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    * Form 4: SEC 1474 (03-26)
    Get the next $HNGE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HNGE

    DatePrice TargetRatingAnalyst
    1/9/2026$68.00Overweight
    Wells Fargo
    9/5/2025$56.00Neutral
    Robert W. Baird
    7/14/2025$58.00Mkt Outperform
    Citizens JMP
    6/16/2025Outperform
    William Blair
    6/16/2025$48.00Buy
    Truist
    6/16/2025$48.00Buy
    Stifel
    6/16/2025$45.00Outperform
    Raymond James
    6/16/2025$41.00Overweight
    Piper Sandler
    More analyst ratings

    $HNGE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Robinson Elliott sold 0 shares (SEC Form 4)

    4 - Hinge Health, Inc. (0001673743) (Issuer)

    6/3/26 5:31:31 PM ET
    $HNGE
    EDP Services
    Technology

    Exec. Chairman & Co-Founder Mecklenburg Gabriel M.I. converted options into 83,334 shares and sold $5,018,133 worth of shares (83,334 units at $60.22) as part of a pre-agreed trading plan (SEC Form 4)

    4 - Hinge Health, Inc. (0001673743) (Issuer)

    6/3/26 4:23:42 PM ET
    $HNGE
    EDP Services
    Technology

    Chief Financial Officer Budge James covered exercise/tax liability with 9,986 shares, decreasing direct ownership by 2% to 435,400 units (SEC Form 4) to satisfy withholding obligation

    4 - Hinge Health, Inc. (0001673743) (Issuer)

    6/1/26 7:13:16 PM ET
    $HNGE
    EDP Services
    Technology

    $HNGE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wells Fargo initiated coverage on Hinge Health with a new price target

    Wells Fargo initiated coverage of Hinge Health with a rating of Overweight and set a new price target of $68.00

    1/9/26 9:05:22 AM ET
    $HNGE
    EDP Services
    Technology

    Robert W. Baird initiated coverage on Hinge Health with a new price target

    Robert W. Baird initiated coverage of Hinge Health with a rating of Neutral and set a new price target of $56.00

    9/5/25 7:59:54 AM ET
    $HNGE
    EDP Services
    Technology

    Citizens JMP initiated coverage on Hinge Health with a new price target

    Citizens JMP initiated coverage of Hinge Health with a rating of Mkt Outperform and set a new price target of $58.00

    7/14/25 8:51:47 AM ET
    $HNGE
    EDP Services
    Technology

    $HNGE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hinge Health proven to deliver 3.0x ROI with the largest study of its kind

    The study analyzed over 200,000 participants from nearly 1,000 employers over five years, finding $2,941 savings per member annually Hinge Health, Inc. (NYSE:HNGE) today announced the results of the most comprehensive medical claims analysis of its digital musculoskeletal (MSK) solution, demonstrating an average cost savings of $2,941 per member per year using its chronic MSK program and a 3.0x ROI for employers and health plans. With a rigorous methodology independently reviewed by Howden, a global leading benefits consultant, the study dwarfs all prior ROI studies in digital MSK. It analyzed claims data for more than 200,000 commercially-insured adults ages 18-64 across nearly 1,000 e

    6/3/26 9:20:00 AM ET
    $HNGE
    EDP Services
    Technology

    NYSE Content Update: Hinge Health Shares Up 72% One Year from its IPO

    NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, May 28, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on May 28thTraders are reacting to new developments out of the Middle East following a report that the U.S. carried out strikes on an Iranian military site near the Strait of Hormuz.Shares of Global X NYSE 100 ETF component Snowflake (NYSE:SNOW) are spiking ahead of the open after Q1 earnings and announcing a $6 billion deal wit

    5/28/26 8:55:00 AM ET
    $HNGE
    $ICE
    $NCDL
    EDP Services
    Technology
    Investment Bankers/Brokers/Service
    Finance

    Hinge Health reports record first quarter 2026 financial results

    Hinge Health, Inc. (NYSE:HNGE) today announced financial results for the first quarter ended March 31, 2026. "We generated $182 million in revenue this quarter with 47% year-over-year growth, well ahead of expectations, driven by the strength of a platform that automates care delivery, improves member outcomes and lowers costs," said Daniel Perez, Co-Founder and CEO, Hinge Health. "Based on this momentum, we're raising our full-year revenue outlook by approximately $64 million at the midpoint to $801 million, while expanding non-GAAP operating margin to 26%. We also recently announced our Migraine Care Program, an important step in expanding our platform. We didn't build this company to s

    5/5/26 4:05:00 PM ET
    $HNGE
    EDP Services
    Technology

    $HNGE
    SEC Filings

    View All

    SEC Form 144 filed by Hinge Health Inc.

    144 - Hinge Health, Inc. (0001673743) (Subject)

    5/26/26 4:45:33 PM ET
    $HNGE
    EDP Services
    Technology

    SEC Form 144 filed by Hinge Health Inc.

    144 - Hinge Health, Inc. (0001673743) (Subject)

    5/20/26 4:36:19 PM ET
    $HNGE
    EDP Services
    Technology

    SEC Form 144 filed by Hinge Health Inc.

    144 - Hinge Health, Inc. (0001673743) (Subject)

    5/11/26 4:33:46 PM ET
    $HNGE
    EDP Services
    Technology

    $HNGE
    Financials

    Live finance-specific insights

    View All

    Hinge Health reports record first quarter 2026 financial results

    Hinge Health, Inc. (NYSE:HNGE) today announced financial results for the first quarter ended March 31, 2026. "We generated $182 million in revenue this quarter with 47% year-over-year growth, well ahead of expectations, driven by the strength of a platform that automates care delivery, improves member outcomes and lowers costs," said Daniel Perez, Co-Founder and CEO, Hinge Health. "Based on this momentum, we're raising our full-year revenue outlook by approximately $64 million at the midpoint to $801 million, while expanding non-GAAP operating margin to 26%. We also recently announced our Migraine Care Program, an important step in expanding our platform. We didn't build this company to s

    5/5/26 4:05:00 PM ET
    $HNGE
    EDP Services
    Technology

    Hinge Health to announce first quarter 2026 financial results on May 5, 2026

    Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the quarter ended March 31, 2026, after the U.S. financial markets close on Tuesday, May 5, 2026. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health is focused on scaling and automating the delivery of health care, starting wit

    4/2/26 4:05:00 PM ET
    $HNGE
    EDP Services
    Technology

    Hinge Health to announce fourth quarter and full year 2025 financial results on February 10, 2026

    Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the fourth quarter and full year 2025 after the U.S. financial markets close on Tuesday, February 10, 2026. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health is focused on scaling and automating the delivery of health care, st

    1/14/26 9:00:00 AM ET
    $HNGE
    EDP Services
    Technology

    $HNGE
    Leadership Updates

    Live Leadership Updates

    View All

    Hinge Health appoints Tyler Sloat to its board of directors

    Hinge Health, Inc. (NYSE:HNGE) today announced the addition of Tyler Sloat to its board of directors. Sloat currently serves as the Chief Financial Officer and Chief Operating Officer of Freshworks Inc., where he oversees accounting, finance, IT, security, workplace, corporate strategy and revenue enablement. "Tyler brings decades of deep operating experience," said Daniel Perez, Co-Founder and CEO, Hinge Health. "His track record of scaling public companies with operational rigor and financial discipline will be instrumental as we advance our mission to automate healthcare delivery." As a seasoned executive and board member, Sloat has nearly three decades of operational leadership guid

    3/17/26 4:05:00 PM ET
    $HNGE
    EDP Services
    Technology